Private equity has moved deep into healthcare, and physicians who never imagined selling are now fielding serious offers. The pitch is compelling: a large upfront payment, a partner to handle the business side, capital to grow, and a chance at a “second bite” when the platform sells again. For the right physician and the right deal, it can deliver all of that.
But a physician selling practice to private equity is stepping into a process the buyer runs for a living and the physician usually encounters once. Understanding the PE playbook before you engage, how these firms think, what they want, and what changes after they own your practice, is the difference between a deal that works for you and one that only works for them. This guide walks through what to expect from the seller’s chair.
Why is private equity buying medical practices?
Private equity firms raise money from investors and buy companies with the goal of selling them later at a profit, usually within a defined window. Healthcare has drawn heavy PE interest because medical practices generate steady cash flow, the industry is fragmented, and consolidating many small practices into one larger organization can increase value.
This trend is part of a broader shift in medicine. According to the American Medical Association, the share of physicians in private practice continues to decline as more join larger organizations. Private equity is one of the forces driving that consolidation, particularly in specialties like dermatology, ophthalmology, gastroenterology, orthopedics, anesthesia, and urgent care.
Understanding the firm’s motive matters, because it explains everything else about the deal. A PE buyer is not acquiring your practice to run it forever. It is acquiring your practice to grow it, combine it with others, and sell the larger entity at a higher multiple. Your deal terms are built around that plan.
Platform vs. add-on: which one is your practice?
One of the first things to understand is where your practice fits in the PE firm’s strategy, because it changes your leverage, your role, and often your economics.
| Platform | Add-on | |
|---|---|---|
| What it is | The first, anchor practice the firm builds around | A practice folded into an existing platform |
| Typical size | Larger, well-run, strong management | Smaller; joins an established structure |
| Your leverage | Higher — the firm needs you | Lower — the structure is already set |
| Valuation multiple | Often higher | Often lower than the platform’s |
| Your role after close | Potential leadership in the platform | Integrating into someone else’s system |
Platform deals generally give the selling physician more negotiating power and sometimes a larger role in the combined organization. Add-on deals are usually presented with terms that are closer to fixed, because the platform already has its structure, its governance, and its employment templates. Neither is inherently better, but knowing which one you are helps you understand how much room there is to negotiate and what your day-to-day will look like afterward.
The hold-and-flip timeline: what’s the PE firm’s plan?
Private equity firms operate on a timeline. They typically aim to hold an investment for roughly three to seven years, grow it, and then sell, either to a larger PE firm, a strategic buyer, or through a recapitalization. This is the “hold and flip,” and it drives the physician’s experience more than almost anything else in the deal.
The second sale is where the rollover equity you took can pay off, the so-called second bite of the apple. If the platform grows and sells at a higher multiple, your rolled equity can be worth significantly more than it was at the first closing. That is the upside physicians are sold on, and in strong platforms it is real.
But the timeline cuts both ways. The firm’s incentive is to maximize the value of the whole platform for that second sale, which can mean aggressive growth targets, cost management, standardized operations, and changes to how medicine is practiced across the group. Decisions will be made with the exit in mind. A physician who understands that the entire enterprise is being groomed for resale can evaluate the deal realistically, rather than assuming the status quo will continue.
What changes after a physician sells a practice to private equity?
This is the part physicians most often underestimate. The closing is not the end of the story; it is the start of a new working relationship in which you are no longer the owner.
Control shifts. In most structures, a Management Services Organization takes over the business side, staffing, scheduling, vendor contracts, billing, and much of the operational decision-making, while you retain clinical authority and, often, nominal ownership of the professional entity. How much control you keep depends entirely on the documents. We cover this in depth in our guide on the MSO structure, but the short version is that “you still own the practice” can mean far less than it sounds.
Compensation changes. Your pay usually resets to a new model, often productivity-based, defined by the platform rather than by you. The generous owner’s distributions you may have taken can be replaced by an employed physician’s compensation formula. This is why the employment agreement you sign at closing deserves as much scrutiny as the purchase price itself, a point we cover in our article on the employment agreement after a sale.
Culture changes. Standardization is how platforms create value. That can mean new electronic systems, new protocols, new productivity expectations, and less autonomy over how the office runs. For some physicians this is a welcome relief from administrative burden. For others it is the hardest part of the transition.
How the money actually works
A private equity offer is rarely all cash at closing. The total consideration is usually a mix of components, and each carries different risk:
- Cash at closing. The certain part of the deal, paid up front.
- Rollover equity. A portion of your proceeds reinvested into the buyer’s parent company. This is an at-risk investment, not cash, and its value rides on the platform’s future performance. We break this down in our guide on rollover equity.
- Earnout. Deferred payments contingent on hitting post-closing targets, usually controlled by the buyer.
The headline number a PE firm quotes often blends all three. That is where physicians get misled, not by dishonesty, but by treating uncertain, future-dependent dollars as if they were guaranteed cash. A realistic evaluation separates what is certain from what is contingent, and prices the risk accordingly.
What physicians should evaluate before engaging
Before you sign a letter of intent with a PE buyer, a few questions frame the entire deal:
- Is my practice a platform or an add-on, and what does that mean for my leverage?
- How much of the price is cash versus rollover versus earnout?
- What does the post-closing employment agreement look like, and how does my compensation change?
- How much operational control shifts to the MSO, and what do I actually retain?
- What is the firm’s expected timeline to a second sale, and what are the growth expectations in the meantime?
- What happens to my rollover equity if I leave, retire, or am terminated before the second sale?
These questions are best asked before the letter of intent, because that is when your leverage is highest. Once you sign an LOI with an exclusivity provision, the ability to shape the deal narrows considerably, one of the most common mistakes we see physicians make when selling a practice.
Is selling to private equity a good idea for physicians?
There is no universal answer, and any article claiming otherwise is selling something. A PE sale can be an excellent outcome for a physician nearing retirement who wants to monetize the practice, for a group that needs capital to grow, or for physicians who welcome shedding the administrative side. It can be a poor outcome for a physician who underestimates how much autonomy and income structure will change, or who accepts a headline number without understanding how much of it is contingent.
The deal is neither the windfall the pitch suggests nor the trap the skeptics warn about. It is a sophisticated transaction whose value depends entirely on the terms, and on whether the physician negotiated from understanding or from optimism. The physicians who do best are the ones who treat the offer as the beginning of a negotiation, not a gift to be accepted quickly.
About Med Contract Law. Med Contract Law represents physicians and physician-owned practices on the physician’s side of private equity and strategic transactions, from evaluating the first offer through the employment agreement you sign at closing. We focus on the terms that determine what a deal is really worth: rollover, earnouts, governance, compensation, and control.
If you are a physician selling a practice to private equity, or weighing an unsolicited offer, experienced physician-side counsel can help you understand what you are actually being offered before you commit. Schedule a confidential consultation to talk through your situation.
Frequently asked questions
What does it mean when private equity buys a medical practice? A private equity firm acquires the practice, usually has the physician roll part of the proceeds into equity in the parent company, puts the physician on a new employment agreement, and manages the business toward a second sale in roughly three to seven years. The goal is to grow and resell at a higher value.
What is the difference between a platform and an add-on practice? A platform is the anchor practice a PE firm builds its strategy around, typically larger, with more physician leverage and often a higher valuation multiple. An add-on is folded into an existing platform, usually with less negotiating room because the structure is already set.
How long does a private equity firm keep a practice before selling again? Typically three to seven years. PE firms operate on a hold-and-flip model, growing the platform and then selling to a larger firm or strategic buyer. That timeline shapes growth targets, operational changes, and when rollover equity may pay off.
Will I still control my practice after selling to private equity? Usually less than you expect. In most structures a Management Services Organization takes over the business operations while you retain clinical authority and often nominal ownership of the professional entity. How much control you keep depends entirely on the documents.
What is rollover equity in a private equity practice sale? It is the portion of your proceeds reinvested into the buyer’s parent company rather than paid as cash. It is an at-risk investment whose value depends on the platform’s future performance and whether a profitable second sale occurs. It should not be counted as guaranteed money.
Is selling my practice to private equity a good idea? It depends on the terms and your goals. It can suit a physician nearing retirement, a group needing growth capital, or one wanting to offload administration. It can disappoint a physician who underestimates how much control and compensation change, or who accepts a headline number without understanding how much is contingent.